Data for: Platinum drugs in the Australian cancer chemotherapy healthcare setting: is it worthwhile for chemists to continue to develop platinums?

Published: 20-04-2019| Version 1 | DOI: 10.17632/dhjfv9n8d2.1
Contributors:
Nial Wheate,
Evangeline Armstrong-Gordon,
Irene Um,
Danijela Gnjidic,
Yvonne Moussa

Description

Summary of EviQ (Australian) chemotherapy protocols that recommend a platinum drug (Cisplatin, carboplatin, oxaliplatin).

Files